KMS Medisurgi Ltd
Ticker: KMSMEDI
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
126.50
Market Cap
41.75
Debt/Equity
0.1125
ROE %
5.587
PB
5.1601
Promoter %
74.424
Pledge %
0.000
1Y Rev Growth %
0.000
5Y Rev Growth %
6.203
NP Margin %
3.150
NP Margin 5Y Avg %
3.102
Trading Reference
1M Return %
0.000
6M Return %
-0.315
1Y Return %
1.200
% Away 52W High
4.585
% Away 52W Low
4.979
Daily Volume
27000
Investment Verdict
Risky
Score 47/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 28/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
KMS Medisurgi Ltd is currently trading near a key support level, with recent volume indicating increased buying interest. If it breaks above the resistance level established at the recent highs, there is potential for a bullish trend. However, if it falls below the support, it may indicate bearish sentiment. Therefore, the probability of an upward movement is higher given the current technical indicators.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
G
Gem Spinners India Ltd
Gem Spinners India Ltd shows potential but faces significant risks and inconsistencies in growth and profitability, making it a risky investment at this time.
View details
P
Prime Urban Development India Ltd
While Prime Urban Development India Ltd operates in a potentially growth-oriented sector, its inconsistent financial performance and governance issues raise concerns. Caution is advised for potential investors.
View details
N
Neelam Linens and Garments (India) Ltd
The stock presents significant risks with inconsistent growth and profitability metrics, alongside valuation concerns.
View details
N
Nippon India ETF Nifty 50 Value 20
The ETF presents a decent investment opportunity with stable growth and profitability metrics, but caution is advised due to execution risks and governance concerns.
View details
N
Next Mediaworks Ltd
Next Mediaworks Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
T
Tapi Fruit Processing Ltd
Tapi Fruit Processing Ltd shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
View details
P
Pentagon Rubber Ltd
Pentagon Rubber Ltd presents several risks with inconsistent growth and average profitability metrics, making it a risky investment at this time.
View details
A
Ashoka Metcast Ltd
The stock presents several risks with inconsistent growth and profitability metrics, suggesting caution for potential investors.
View details
M
Mardia Samyoung Capillary Tubes Company Ltd
The company shows potential but faces significant risks and inconsistencies in growth and profitability.
View details
A
Arunaya Organics Ltd
Arunaya Organics Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks. Caution is advised for investors.
View details
S
Sprayking Ltd
Sprayking Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
V
Vandan Foods Ltd
Vandan Foods Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
H
H P Cotton Textile Mills Ltd
H P Cotton Textile Mills Ltd shows some potential but faces significant challenges that could hinder growth and profitability.
View details
S
Shreenath Paper Products Ltd
Shreenath Paper Products Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Suryaamba Spinning Mills Ltd
Suryaamba Spinning Mills Ltd presents a risky investment profile with inconsistent growth and profitability metrics, coupled with governance concerns.
View details
M
Medicamen Organics Ltd
Medicamen Organics Ltd shows potential for growth but faces several challenges that could impact its performance.
View details
Business Overview
KMS Medisurgi Ltd is a leading provider of medical and surgical equipment in India, dedicated to enhancing healthcare delivery across the nation. Catering to hospitals, clinics, and healthcare professionals, the company focuses on quality and innovation to improve patient outcomes. With a commitment to reliability and excellence, KMS Medisurgi Ltd plays a crucial role in supporting the healthcare ecosystem.
- Established leader in medical equipment
- Serves hospitals and healthcare professionals
- Focus on quality and innovation
- Enhances patient care and outcomes
- Committed to reliability and excellence
Investment Thesis
KMS Medisurgi Ltd presents a compelling investment opportunity driven by a strong promoter group with a solid track record, significant growth potential in digital services, and attractive valuation compared to its peers. This combination positions the company for sustainable growth and value creation.
- Strong promoter credibility ensures effective governance and strategic direction.
- Digital services segment poised for robust growth, tapping into increasing healthcare digitization.
- Valuation metrics indicate KMS Medisurgi is undervalued relative to industry peers.
- Diversified product offerings mitigate risks and enhance revenue streams.
- Positive market trends and government initiatives support healthcare sector expansion.
Opportunity vs Risk
Opportunities
- Growing healthcare demand in India
- Expansion into new markets
- Innovative product pipeline
- Strong partnerships with hospitals
- Government support for healthcare sector
Risks ⚠️
- Regulatory changes impacting operations
- Intense competition in the sector
- Supply chain disruptions
- High dependency on key products
- Economic downturn affecting spending
Peer Perspective
KMS Medisurgi Ltd trades at a discount to peers like Apollo Hospitals and Fortis Healthcare, primarily due to margin stability concerns. A sustained improvement in operational efficiency could trigger a rerating in its valuation.
Future Outlook
KMS Medisurgi Ltd has strong growth potential driven by innovative product development and expanding market reach; however, successful execution and stringent cost control will be crucial to fully realize these opportunities.
AI FAQs for Retail Users
- Q: What does KMS Medisurgi Ltd do?A: KMS Medisurgi Ltd specializes in medical devices and surgical instruments for healthcare providers.
- Q: Is KMS Medisurgi Ltd a profitable company?A: Profitability can vary; check recent financial reports for the latest performance metrics.
- Q: What are the risks of investing in KMS Medisurgi Ltd?A: Risks include market competition, regulatory changes, and economic factors affecting the healthcare sector.
- Q: How can I buy shares of KMS Medisurgi Ltd?A: Shares can be purchased through a registered stockbroker or online trading platform.
- Q: Where can I find financial updates on KMS Medisurgi Ltd?A: Financial updates are available on the company's website and through stock market news platforms.
📊 Stock Investment Checklist (100 Points)
KMS Medisurgi Ltd • Updated: 2025-09-17 03:09:37
-
8BusinessHighThe sector is growing with increasing healthcare demands, but competition is high.
-
10GrowthHighRevenue growth has been inconsistent, with some fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is not consistently strong.
-
9ValuationHighValuation metrics are slightly above peers, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is reasonable, but there are some concerns about disclosures.
-
5DriversGoodGrowth drivers exist, but execution risks are significant.
-
1TechnicalsLowMarket sentiment is weak with low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
KMS Medisurgi Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100